BostonGene has developed biomedical software that is specifically designed to carry out advanced patient analysis and personalized therapy. This platform carries out analytics based on each patient's genetics, tumor, tumor microenvironment, clinical characteristics, and disease profile. This valuable tool assists clinicians in assessing potential treatment options.

Investors Include:

NEC (Japan), Japan Industrial Partners, Impact Investment Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund